Physician profile
Michael S Rocca
NPI 1962963926
$8,962.93
in general payments reported to CMS, 2019-2025
8 companies · $4,752 in 2025
The $4,752 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,211 · 2025: $4,752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $7,000 · Food and Beverage: $1,963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $7,000.00 |
| Food and Beverage | $1,962.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,162.72 | 2024-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $675.87 | 2024-2025 | Alphavent, Salvation, Blueprint Patient Specific Instrumentation |
| Mid-Atlantic Surgical Systems, LLC | $385.81 | 2024-2025 | |
| Polaris Technology Solutions LLC | $243.09 | 2025 | |
| Arthrex, INC. | $232.00 | 2025 | |
| Davol INC. | $162.48 | 2024 | Arista Ah Flexitip |
| Prism Medical | $78.73 | 2025 | |
| Zimmer Biomet Holdings, INC. | $22.23 | 2025 | Activbraid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rocca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.